End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
745,000 KRW | -1.32% | -4.36% | -1.97% |
May. 23 | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.97% | 39.03B | |
-2.95% | 90.75B | |
-15.47% | 31.85B | |
+62.48% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+2.85% | 8.89B | |
-16.26% | 7.67B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics Posts Higher Q1 Profit, Sales